Literature DB >> 2409081

Epidermal growth factor stimulates the phosphorylation of the calcium-dependent 35,000-dalton substrate in intact A-431 cells.

S T Sawyer, S Cohen.   

Abstract

We have previously reported the isolation of a 35-kDa protein from A-431 cells that, in the presence of Ca2+, is an excellent in vitro substrate for the epidermal growth factor (EGF) receptor/kinase present in membrane preparations (Fava, R. A., and Cohen, S. (1984) J. Biol. Chem. 259, 2636-2645). In this communication we demonstrate that the phosphorylation of the 35-kDa protein is markedly enhanced in intact, 32P-labeled, A-431 cells following exposure of the cells to EGF. The 35-kDa protein immunoprecipitated from cells treated with EGF is phosphorylated to a 20-120-fold greater extent than comparable preparations from control cells. Both phosphotyrosine and phosphoserine residues are detected in the protein after treatment of the cells with EGF. EGF-dependent phosphorylation of the 35-kDa protein is barely detected unless the intact cells are exposed to EGF for periods greater than 5 min. We suggest that endosomes containing internalized EGF X receptor/kinase complexes are primarily responsible for the observed phosphorylation of the 35-kDa protein in intact cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2409081

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  Transmembrane signalling at the epidermal growth factor receptor. Positive regulation by the C-terminal phosphotyrosine residues.

Authors:  M Magni; A Pandiella; K Helin; J Meldolesi; L Beguinot
Journal:  Biochem J       Date:  1991-07-15       Impact factor: 3.857

2.  Origins of growth factors: NGF and EGF.

Authors:  Stanley Cohen
Journal:  J Biol Chem       Date:  2008-08-12       Impact factor: 5.157

3.  Cell cycle and post-transcriptional regulation of annexin expression in IMR-90 human fibroblasts.

Authors:  P Raynal; H B Pollard; M Srivastava
Journal:  Biochem J       Date:  1997-03-01       Impact factor: 3.857

4.  Two related but distinct forms of the Mr 36,000 tyrosine kinase substrate (calpactin) that interact with phospholipid and actin in a Ca2+-dependent manner.

Authors:  J Glenney
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

5.  Synthesis of p36 and p35 is increased when U-937 cells differentiate in culture but expression is not inducible by glucocorticoids.

Authors:  C M Isacke; R A Lindberg; T Hunter
Journal:  Mol Cell Biol       Date:  1989-01       Impact factor: 4.272

6.  iTRAQ-based quantitative proteomic analysis of differentially expressed proteins in chemoresistant nasopharyngeal carcinoma.

Authors:  Kun Wang; Zhen Chen; Lu Long; Ya Tao; Qiong Wu; Manlin Xiang; Yunlai Liang; Xulin Xie; Yuan Jiang; Zhiqiang Xiao; Yahui Yan; Shiyang Qiu; Bin Yi
Journal:  Cancer Biol Ther       Date:  2018-08-01       Impact factor: 4.742

7.  Identification and subcellular localization of proteins that are rapidly phosphorylated in tyrosine in response to colony-stimulating factor 1.

Authors:  A Sengupta; W K Liu; Y G Yeung; D C Yeung; A R Frackelton; E R Stanley
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

8.  Modulation of p36 phosphorylation in human cells: studies using anti-p36 monoclonal antibodies.

Authors:  C M Isacke; I S Trowbridge; T Hunter
Journal:  Mol Cell Biol       Date:  1986-07       Impact factor: 4.272

9.  A 36 kDa monomeric protein and its complex with a 10 kDa protein both isolated from bovine aorta are calpactin-like proteins that differ in their Ca2+-dependent calmodulin-binding and actin-severing properties.

Authors:  F Martin; J Derancourt; J P Capony; A Watrin; J C Cavadore
Journal:  Biochem J       Date:  1988-05-01       Impact factor: 3.857

10.  Expression of annexin II in conventional renal cell carcinoma is correlated with Fuhrman grade and clinical outcome.

Authors:  U Zimmermann; C Woenckhaus; S Pietschmann; H Junker; S Maile; K Schultz; C Protzel; J Giebel
Journal:  Virchows Arch       Date:  2004-08-26       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.